Revance Therapeutics Inc (RVNC)
3.32
-0.97
(-22.61%)
USD |
NASDAQ |
May 10, 16:00
3.31
-0.01
(-0.30%)
After-Hours: 20:00
Revance Therapeutics Stock Buybacks (Quarterly): 0.00 for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | -100.18M |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | -216.20M |
June 30, 2022 | -22.82M |
March 31, 2022 | -8.997M |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.001M |
June 30, 2021 | -0.001M |
March 31, 2021 | -21.71M |
December 31, 2020 | -68.37M |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | -15.58M |
December 31, 2019 | -114.74M |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | -108.10M |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
Date | Value |
---|---|
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | -157.47M |
September 30, 2017 | -9.66M |
June 30, 2017 | -2.883M |
March 31, 2017 | -26.22M |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | -126.10M |
September 30, 2015 | -10.15M |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | 0.002M |
September 30, 2014 | 0.00 |
June 30, 2014 | -131.88M |
March 31, 2014 | -102.67M |
December 31, 2013 | |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-216.20M
Minimum
Sep 2022
0.001M
Maximum
Sep 2021
-29.93M
Average
--
Median
Jun 2019
Stock Buybacks (Quarterly) Benchmarks
AbbVie Inc | 1.324B |
Eli Lilly and Co | 0.00 |
Aquestive Therapeutics Inc | -82.10M |
Humacyte Inc | -- |
AN2 Therapeutics Inc | 0.321M |